Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04743765 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Study acronym: HIP ATTACK-2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Feb 28, 2027 → Aug 31, 2027
See other at-risk trials from Population Health Research Institute

Record History

  1. Primary completion pushed from Feb 28, 2027 to Aug 31, 2027 Trial sites expanded: 70 → 77 locations · Completion pushed from May 31, 2027 to Nov 30, 2027v42 Show 2 more changesShow less
    • Trial sites expanded: 70 → 77 locations
    • Completion pushed from May 31, 2027 to Nov 30, 2027
  2. Study sites: 69 to 70v41
  3. Study sites: 68 to 69v40
  4. Study sites: 67 to 68v39
  5. Study sites: 66 to 67v38
Show 36 earlier versionsHide 36 earlier versions
  1. Study sites: 65 to 66v37
  2. Study sites: 59 to 65v36
  3. Study sites: 55 to 59v35
  4. Study sites: 53 to 55v34
  5. Study sites: 52 to 53v33
  6. Site contacts updated at 1 of 52 sitesv32
  7. Primary completion date: Apr 15, 2025 to Feb 28, 2027 Completion date: Jul 15, 2025 to May 31, 2027 · Eligibility criteria expanded, about 26 words · Secondary endpoints: details revised at 2 of 10 entries · 1 morev31 Show 4 more changesShow less
    • Completion date: Jul 15, 2025 to May 31, 2027
    • Eligibility criteria expanded, about 26 words
    • Secondary endpoints: details revised at 2 of 10 entries
    • Collaborators: 1 to 2

    See this version in full on ClinicalTrials.gov ↗

  8. Study sites: 50 to 52v30
  9. Study sites: 49 to 50v29
  10. Study sites: 48 to 49v28
  11. Study sites: 47 to 48v27
  12. Study sites: 46 to 47v26
  13. Study sites: 45 to 46v25
  14. Study sites: 44 to 45v24
  15. Study sites: 43 to 44v23
  16. Study sites: 42 to 43v22
  17. Study sites: 41 to 42v21
  18. Study sites: 40 to 41v20
  19. Study sites: 39 to 40v19
  20. Study sites: 38 to 39v18
  21. Study sites: 37 to 38v17
  22. Study sites: 36 to 37v16
  23. Study sites: 35 to 36v15
  24. Study sites: 34 to 35v14
  25. Study sites: 33 to 34v13
  26. Study sites: 32 to 33v12
  27. Site contacts updated at 5 of 32 sitesv11
  28. Study sites: 31 to 32v10
  29. Study sites: 30 to 31v9
  30. Study sites: 29 to 30v8
  31. Study sites: 28 to 29v7
  32. Study sites: 27 to 28v6
  33. Study sites: 19 to 27v5
  34. Study sites: 1 to 19v4
  35. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Nov 1, 2021 to Nov 22, 2021v3 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 1, 2021 to Nov 22, 2021
  36. Start date: Apr 15, 2021 to Nov 1, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.
Trial Details
NCT Number NCT04743765
Lead Sponsor Population Health Research Institute
Collaborators: Canadian Institutes of Health Research (CIHR), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions Hip Fractures, Myocardial Injury
Enrollment 1,100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov